Pillar 4: Safety as Duty and Responsibility

Safety in bleeding disorders must be permanent, transparent, and enforced; not a promise made once, but a system built to last. This pillar treats safety not as a one-time check, but as an enduring responsibility. It includes long-term treatment surveillance, blood product accountability, strong recall protocols, and meaningful patient oversight, especially as new therapies like gene therapy and cell therapy reshape the landscape of bleeding disorders care.

The policy priorities listed below will change in the coming months as HFA works to redesign our policy work and provide the community with new education and policy documents.